Platform Therapeutics, Inc.
ANDOVER, MA · CIK 0002152141 · Biotech
- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $1.8M
- 1 Form D · Aug 2026
- 1 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20262027
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,750,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2185 | OCULOGENEX | — | — |
| 2186 | BIOSUPERIOR TECHNOLOGY INC | — | — |
| 2187 | NexImmune, Inc. | — | $35M |
| 2188 | Platform Therapeutics, Inc. | — | $1.8M |
| 2189 | Ceapro Inc. | — | $7.7M |
| 2190 | GREENSTONE BIOSCIENCES, INC. | — | $10M |
| 2191 | SILCSBIO LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.